|Home | About | Journals | Submit | Contact Us | Français|
In December 2016, the Indian Journal of Critical Care Medicine published our review article on the current management of acute aluminum phosphide toxicity, as well as our new proposals for therapy. One month later, in the first issue of 2017, Hassanian-Moghaddam and Zamani raised some concerns in the review. We appreciate their interest in our article and would like to address the concerns.
Lastly, we think acute aluminum phosphide poisoning is not an irremediable situation, but sophism in its management may cause patient harm. According to our previous experience, it seems that following the new proposals for therapy can improve survival. However, without a randomized controlled trial, everything is just a “claim.”
There are no conflicts of interest.